HomeNewsTrendsCoronavirus lockdown | Tirupati temple struggling to pay its 23,000 staffers after losing Rs 400 crore in revenue

Coronavirus lockdown | Tirupati temple struggling to pay its 23,000 staffers after losing Rs 400 crore in revenue

The TTD has spent almost Rs 300 crore on paying salaries, pensions, etc., already and is now exploring ways to resolve the looming financial crisis through means other than falling back on its Rs 14,000 crore fixed deposits or eight tonnes of gold reserve

May 12, 2020 / 13:57 IST
Story continues below Advertisement
Representative Image
Representative Image

The world’s richest temple trust, Tirumala Tirupati Devasthanams (TTD), is reportedly struggling to pay its employees after suffering a loss of revenue totalling Rs 400 crore due to the nationwide coronavirus lockdown.

The members of the trust have claimed that the Tirupati temple, that attracts nearly 1,00,000 devotees daily, has not opened its doors to them for the past 50 days. As a result, its revenue has hit rock bottom, reported the Times of India.

Story continues below Advertisement

As the temple coffers are emptying fast, the trust is struggling to pay salaries to its 23,000 staffers. They are also finding it difficult to meet daily expenses as even in the absence of devotees, the daily and weekly rituals and festivals are being observed inside the temple premises as usual.

For live updates on coronavirus, click here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show